凯普生物：关于全资子公司取得医疗器械注册证书的公告

Core Viewpoint - The company, Capbio, announced that its wholly-owned subsidiary, Guangzhou Capbio Medical Technology Co., Ltd., has obtained the Medical Device Registration Certificate for in vitro diagnostic reagents from the National Medical Products Administration of China for its six-pathogen respiratory nucleic acid detection kit (PCR-fluorescent probe method) [2] Group 1 - Capbio's subsidiary has received regulatory approval for a new diagnostic product [2] - The approved product is designed for the detection of multiple respiratory pathogens [2]